Regentis Biomaterials (RGNT) Invested Capital (2024 - 2025)

Regentis Biomaterials' (RGNT) quarterly Invested Capital came in at $1.2 million in Q4 2025, up 108.9% year-on-year from $573000.0 in Q4 2024, and up 108.9% on a QoQ basis from $573000.0 in Q4 2024.

Regentis Biomaterials (RGNT) Invested Capital (2024 - 2025) Analysis & Trends

Regentis Biomaterials (RGNT) has 2 years of Invested Capital data on file, last reported at $1.2 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 2.57 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 77.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 259.93 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 598.90 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 208.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Regentis Biomaterials 1.10 Mn -6.28 Mn - 1.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.20 Mn
Dec 31, 2024 573,000.00